Regeneron Pharmaceuticals Inc (REGN)

505.13 -8.94  -1.74% NASDAQ Dec 2, 20:00 USD

Regeneron Pharmaceuticals Cash from Financing (TTM):

-2.011B for Sept. 30, 2020
View 4,000+ financial data types
Browse...
View Full Chart

Cash from Financing (TTM) Chart

Export Data
Save Image
Print Image

Historical Cash from Financing (TTM) Data

View and export this data going back to 1992. Start your Free Trial
Export Data Date Range:
Data for this Date Range  
Sept. 30, 2020 -2.011B
June 30, 2020 -2.634B
March 31, 2020 -36.40M
Dec. 31, 2019 -252.10M
Sept. 30, 2019 10.60M
June 30, 2019 25.30M
March 31, 2019 29.40M
Dec. 31, 2018 -77.10M
Sept. 30, 2018 -204.64M
June 30, 2018 -216.53M
March 31, 2018 -71.81M
Dec. 31, 2017 -24.40M
Sept. 30, 2017 -305.65M
June 30, 2017 -268.78M
March 31, 2017 -433.50M
Dec. 31, 2016 -700.50M
Sept. 30, 2016 -212.72M
June 30, 2016 -587.04M
March 31, 2016 -559.38M
Dec. 31, 2015 -262.80M
Sept. 30, 2015 -511.44M
June 30, 2015 -160.63M
March 31, 2015 -237.10M
Dec. 31, 2014 -218.55M
Sept. 30, 2014 134.72M
   
June 30, 2014 133.09M
March 31, 2014 169.62M
Dec. 31, 2013 72.19M
Sept. 30, 2013 -101.44M
June 30, 2013 -106.78M
March 31, 2013 -68.37M
Dec. 31, 2012 -97.65M
Sept. 30, 2012 336.80M
June 30, 2012 338.33M
March 31, 2012 353.46M
Dec. 31, 2011 384.25M
Sept. 30, 2011 205.57M
June 30, 2011 207.46M
March 31, 2011 200.13M
Dec. 31, 2010 243.31M
Sept. 30, 2010 82.88M
June 30, 2010 83.41M
March 31, 2010 81.36M
Dec. 31, 2009 31.36M
Sept. 30, 2009 -106.68M
June 30, 2009 -107.51M
March 31, 2009 -188.54M
Dec. 31, 2008 -192.86M
Sept. 30, 2008 237.09M
June 30, 2008 236.11M

There is no data for the selected date range.

An error occurred. Please try again by refreshing your browser or contact us with details of your problem.

Advertisement

Cash From Financing Definition

Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.

Read full definition.

Cash from Financing (TTM) Benchmarks

Moderna Inc 2.020B
Amgen Inc -3.206B
Gilead Sciences Inc -257.00M

Cash from Financing (TTM) Range, Past 5 Years

Minimum -2.634B Jun 2020
Maximum 29.40M Mar 2019
Average -439.64M

News

Top Stocks for December 2020
Yahoo 11/30 15:51 ET
Advertisement

{{root.upsell.info.feature_headline}}.

{{root.upsell.info.feature_description}}

Please note that this feature is only available as an add-on to YCharts subscriptions.


Please note that this feature requires full activation of your account and is not permitted during the free trial period.

Start My Free Trial {{root.upsell.info.call_to_action}} No credit card required.

Already a subscriber? Sign in.